160 related articles for article (PubMed ID: 38048862)
21. FTO-targeted siRNA delivery by MSC-derived exosomes synergistically alleviates dopaminergic neuronal death in Parkinson's disease via m6A-dependent regulation of ATM mRNA.
Geng Y; Long X; Zhang Y; Wang Y; You G; Guo W; Zhuang G; Zhang Y; Cheng X; Yuan Z; Zan J
J Transl Med; 2023 Sep; 21(1):652. PubMed ID: 37737187
[TBL] [Abstract][Full Text] [Related]
22. RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.
Wang J; Fu Q; Yang J; Liu JL; Hou SM; Huang X; Cao JS; Liu TL; Wang KZ
Aging (Albany NY); 2021 Sep; 13(17):21134-21141. PubMed ID: 34496349
[TBL] [Abstract][Full Text] [Related]
23. Exosomes from BM-MSCs promote acute myeloid leukemia cell proliferation, invasion and chemoresistance via upregulation of S100A4.
Lyu T; Wang Y; Li D; Yang H; Qin B; Zhang W; Li Z; Cheng C; Zhang B; Guo R; Song Y
Exp Hematol Oncol; 2021 Mar; 10(1):24. PubMed ID: 33789743
[TBL] [Abstract][Full Text] [Related]
24. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
[No Abstract] [Full Text] [Related]
25. Bone mesenchymal stem cell-derived exosomal microRNA-7-5p inhibits progression of acute myeloid leukemia by targeting OSBPL11.
Jiang D; Wu X; Sun X; Tan W; Dai X; Xie Y; Du A; Zhao Q
J Nanobiotechnology; 2022 Jan; 20(1):29. PubMed ID: 35012554
[TBL] [Abstract][Full Text] [Related]
26. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
[TBL] [Abstract][Full Text] [Related]
27. Lentivirus-mediated IL-10-expressing Bone Marrow Mesenchymal Stem Cells promote corneal allograft survival
Lu X; Ru Y; Chu C; Lv Y; Gao Y; Jia Z; Huang Y; Zhang Y; Zhao S
Theranostics; 2020; 10(18):8446-8467. PubMed ID: 32724480
[No Abstract] [Full Text] [Related]
28. FTO-stabilized miR-139-5p targets ZNF217 to suppress prostate cancer cell malignancies by inactivating the PI3K/Akt/mTOR signal pathway.
Azhati B; Reheman A; Dilixiati D; Rexiati M
Arch Biochem Biophys; 2023 Jun; 741():109604. PubMed ID: 37080415
[TBL] [Abstract][Full Text] [Related]
29. TNF-α suppresses sweat gland differentiation of MSCs by reducing FTO-mediated m
Wang Y; Wang R; Yao B; Hu T; Li Z; Liu Y; Cui X; Cheng L; Song W; Huang S; Fu X
Sci China Life Sci; 2020 Jan; 63(1):80-91. PubMed ID: 31637575
[TBL] [Abstract][Full Text] [Related]
30. Senescent neutrophils-derived exosomal piRNA-17560 promotes chemoresistance and EMT of breast cancer via FTO-mediated m6A demethylation.
Ou B; Liu Y; Gao Z; Xu J; Yan Y; Li Y; Zhang J
Cell Death Dis; 2022 Oct; 13(10):905. PubMed ID: 36302751
[TBL] [Abstract][Full Text] [Related]
31. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
[TBL] [Abstract][Full Text] [Related]
32. An oncogenic lncRNA, GLCC1, promotes tumorigenesis in gastric carcinoma by enhancing the c-Myc/IGF2BP1 interaction.
Yang DL; Dong LF; Qiu YB; Luo GY
Neoplasma; 2021 Sep; 68(5):1052-1062. PubMed ID: 34196212
[TBL] [Abstract][Full Text] [Related]
33. Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner.
Xiao P; Liu YK; Han W; Hu Y; Zhang BY; Liu WL
Mol Cancer Res; 2021 Apr; 19(4):726-738. PubMed ID: 33563765
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
[TBL] [Abstract][Full Text] [Related]
35. Bone Marrow Mesenchymal Stem Cells-Derived Exosomal miR-425-5p Inhibits Acute Myeloid Leukemia Cell Proliferation, Apoptosis, Invasion and Migration by Targeting WTAP.
Zhang L; Khadka B; Wu J; Feng Y; Long B; Xiao R; Liu J
Onco Targets Ther; 2021; 14():4901-4914. PubMed ID: 34594112
[TBL] [Abstract][Full Text] [Related]
36. The m
Chen LS; Zhang M; Chen P; Xiong XF; Liu PQ; Wang HB; Wang JJ; Shen J
Acta Pharmacol Sin; 2022 May; 43(5):1311-1323. PubMed ID: 34462564
[TBL] [Abstract][Full Text] [Related]
37. Acute Myeloid Leukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities.
Zhang L; Zhao Q; Cang H; Wang Z; Hu X; Pan R; Yang Y; Chen Y
Adv Sci (Weinh); 2022 Jun; 9(16):2105811. PubMed ID: 35686138
[TBL] [Abstract][Full Text] [Related]
38. Bone Marrow Mesenchymal Stem Cell-Derived Exosomal KLF4 Alleviated Ischemic Stroke Through Inhibiting N6-Methyladenosine Modification Level of Drp1 by Targeting lncRNA-ZFAS1.
Wang QS; Xiao RJ; Peng J; Yu ZT; Fu JQ; Xia Y
Mol Neurobiol; 2023 Jul; 60(7):3945-3962. PubMed ID: 37002530
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA DANCR confers cytarabine resistance in acute myeloid leukemia by activating autophagy via the miR-874-3P/ATG16L1 axis.
Zhang H; Liu L; Chen L; Liu H; Ren S; Tao Y
Mol Oncol; 2021 Apr; 15(4):1203-1216. PubMed ID: 33638615
[TBL] [Abstract][Full Text] [Related]
40. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
